Breast cancer
Results
Phase 3
This trial was for people whose breast cancer has spread to the surrounding tissue (locally advanced) or to another part of the body (secondary breast cancer). They had already had treatment with both trastuzumab (Herceptin) and lapatinib.
Recruitment start: 1 September 2011
Recruitment end: 25 October 2012
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Stephen Houston
Experimental Cancer Medicine Centre (ECMC)
F. Hoffmann-LaRoche
NIHR Clinical Research Network: Cancer
Last reviewed: 26 July 2016
CRUK internal database number: 8909
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
